Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Extension Study of BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age

NCT01852058 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01852058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01852058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Extension Study of BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
January 11, 2014
Completion date
October 3, 2019
Enrollment
95 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

urinary incontinence